Non-Executive Director of Publicly Listed biotechnology company
Our client is a highly specialised biotechnology company developing innovative therapies in the field of rare diseases. Having successfully completed a public offering on the Nasdaq, the CEO retained Liftstream to conduct a search for a new independent Board director who would bring extensive experience of the global drug development industry. This search was aimed at securing the services of a new independent Board director who would replace a venture capital investor currently occupying a Board seat, but who would leave the Board as it strives for greater independence and improved governance.
Liftstream conducted an extensive search of the US and European markets for suitably qualified candidates who presented the qualities and experience necessary to contribute to the Board. We shortlisted female and male candidates coming from both US and EU markets and the executive nomination committee selected a highly credible and notable female candidate from the U.S.
This search combined Liftstream’s acute knowledge of rare diseases, our ability to conduct searches internationally, as well as our commitment to gender diversity in Board and executive appointments.